Translational control: The cancer connection

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 1, 1999, Pages 1-23

  Clemens, Michael J ^a   Bommer, Ulrich Axel ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

MRNA structure; Oncogenesis; Polypeptide chain initiation factors; Signal transduction; Translation

Indexed keywords

INITIATION FACTOR; INITIATION FACTOR 2; MESSENGER RNA; PROTEIN KINASE;

APOPTOSIS; CANCER; CARCINOGENESIS; CELL GROWTH; CELL TRANSFORMATION; CYTOLOGY; GROWTH REGULATION; HUMAN; NONHUMAN; PROTEIN SYNTHESIS REGULATION; REVIEW; RNA STRUCTURE; TRANSLATION REGULATION;

EID: 0033045294     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00127-7     Document Type: Review

References (165)

1. D.R. Morris, Growth control of translation in mammalian cells, Progr. Nucleic Acids Res. Mol. Biol. 51 (1995) 339-363.
2. V.M. Pain, Initiation of protein synthesis in eukaryotic cells, Eur. J. Biochem. 236 (1996) 747-771.
3. L.E. Hake, J.D. Richter, Translational regulation of maternal mRNA, Biochim. Biophys. Acta 1332 (1997) M31-M38.
4. M. Kleijn, G.C. Scheper, H.O. Voorma, A.A.M. Thomas, Regulation of translation initiation factors by signal transduction, Eur. J. Biochem. 253 (1998) 531-544.
5. N. Sonenberg, Translation factors as effectors of cell growth and tumorigenesis, Curr. Opin. Cell Biol. 5 (1993) 955-960.
6. N. Sonenberg, Regulation of translation and cell growth by eIF-4E, Biochimie 76 (1994) 839-846.
7. A. Flynn, C.G. Proud, The role of eIF4 in cell proliferation, Cancer Surv. 27 (1996) 293-310.
8. N. Sonenberg, A.C. Gingras, The mRNA 5′ cap-binding protein eIF4E and control of cell growth, Curr. Opin. Cell Biol. 10 (1998) 268-275.
9. J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational control, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1996.
10. S.J. Morley, P.S. Curtis, V.M. Pain, eIF4G: Translation's mystery factor begins to yield its secrets, RNA 3 (1997) 1085-1104.
11. B.L.J. Webb, C.G. Proud, Eukaryotic initiation factor 2B (eIF2B), Int. J. Biochem. Cell Biol. 29 (1997) 1127-1131.
12. S.R. Kimball, Molecules in focus: eukaryotic initiation factor eIF2. Int. J. Biochem. Cell Biol. 31 (1999) 25-29.
13. L. McKendrick, V.M. Pain, S.J. Morley, Molecules in focus: translation initiation factor 4E. Int. J. Biochem. Cell Biol. 31 (1999) 31-35.
14. B. Raught, A.-C. Gingras, eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell Biol. 31 (1999) 43-57.
15. H.C. Palfrey, A.C. Nairn, Calcium-dependent regulation of protein synthesis, Adv. Second Messenger Phosphoprotein Res. 30 (1995) 191-223.
16. N.T. Redpath, E.J. Foulstone, C.G. Proud, Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway, EMBO J. 15 (1996) 2291-2297.
17. N.T. Redpath, N.T. Price, C.G. Proud, Cloning and expression of cDNA encoding protein synthesis elongation factor-2 kinase, J. Biol. Chem. 271 (1996) 17547-17554.
18. S.J. Morley, Regulation of components of the translational machinery by protein phosphorylation, in: Clemens M.J. (Ed.), Protein Phosphorylation in Cell Growth Regulation, Harwood Academic Publishers, Amsterdam, 1996.
19. M.J. Clemens, Protein kinases that phosphorylate eIF2 and eIF2B, and their role in eukaryotic cell translational control, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational control, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1996, pp. 139-172.
20. M.J. Clemens, A. Elia, The double-stranded RNA-dependent protein kinase PKR: Structure and function, J. Interferon Cytokine Res. 17 (1997) 503-524.
21. Wek et al., personal communication.
22. A.J. Waskiewicz, A. Flynn, C.G. Proud, J.A. Cooper, Mitogen-activated protein kinases activate the serine/ threonine kinases Mnk1 and Mnk2, EMBO J. 16 (1997) 1909-1920.
23. R. Fukunaga, T. Hunter, MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates, EMBO, J. 16 (1997) 1921-1933.
24. C.G. Proud, p70 S6 kinase: An enigma with variations, Trends Biochem. Sci. 21 (1996) 181-185.
25. A. Lazaris-Karatzas, K.S. Montine, N. Sonenberg, Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap, Nature 345 (1990) 544-547.
26. T. Fukuchi-Shimogori, I. Ishii, K. Kashiwagi, H. Mashiba, H. Ekimoto, K. Igarashi, Malignant transformation by overproduction of translation initiation factor eIF4G, Cancer Res. 57 (1997) 5041-5044.
27. A.E. Koromilas, S. Roy, G.N. Barber, M.G. Katze, N. Sonenberg, Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase, Science 257 (1992) 1685-1689.
28. E.F. Meurs, J. Galabru, G.N. Barber, M.G. Katze, A.G. Hovanessian, Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase, Proc. Natl. Acad. Sci. USA 90 (1993) 232-236.
29. G.N. Barber, M. Wambach, S. Thompson, R. Jagus, M.G. Katze, Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation, Mol. Cell. Biol. 15 (1995) 3138-3146.
30. O. Donzé, R. Jagus, A.E. Koromilas, J.W.B. Hershey, N. Sonenberg, Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells, EMBO J. 14 (1995) 3828-3834.
31. A. Lazaris-Karatzas, M.R. Smith, R.M. Frederickson, M.L. Jaramillo, Y. Liu, H. Kung, N. Sonenberg, Ras mediates translation initiation factor 4E-induced malignant transformation, Genes Dev. 6 (1992) 1631-1642.
32. A. De Benedetti, A.L. Harris, eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31 (1999) 59-72.
33. Y. Miyagi, A. Sugiyama, A. Asai, T. Okazaki, Y. Kuchino, S.J. Kerr, Elevated levels of eukaryotic translation initiation factor eIF-4E, mRNA in a broad spectrum of transformed cell lines, Cancer Lett. 91 (1995) 247-252.
34. V. Kerekatte, K. Smiley, B. Hu, A. Smith, F. Gelder, A. De Benedetti, The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas, Int. J. Cancer 64 (1995) 27-31.
35. C.A. Nathan, P. Carter, L. Liu, B.D. Li, F. Abreo, A. Tudor, S.G. Zimmer, A. De Benedetti, Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas, Oncogene 15 (1997) 1087-1094.
36. B. Anthony, P. Carter, A. De Benedetti, Overexpression of the proto-oncogene translation factor 4E in breast-carcinoma cell lines, Int. J. Cancer 65 (1996) 858-863.
37. C.A. Nathan, L. Liu, B.D. Li, F.W. Abreo, I. Nandy, A. De Benedetti, Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer, Oncogene 15 (1997) 579-584.
38. B.D. Li, L. Liu, M. Dawson, A. De Benedetti, Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma, Cancer 79 (1997) 2385-2390.
39. I. Stein, A. Itin, P. Einat, R. Skaliter, Z. Grossman, E. Keshet, Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia, Mol. Cell. Biol. 18 (1998) 3112-3119.
40. P.A.E. Scott, K. Smith, R. Poulsom, A. De Benedetti, R. Bicknell, A.L. Harris, Differential expression of vascular endothelial growth factor mRNA vs. protein isoform expression in human breast cancer and relationship to eIF-4E, Br. J. Cancer 77 (1998) 2120-2128.
41. R.J. DeFatta, E.A. Turbat-Herrera, B.D.L. Li, W. Anderson, A. De Benedetti, Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia. Int. J. Cancer, 1999, in press.
42. J. Eberle, K. Krasagakis, C.E. Orfanos, Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro, Int. J. Cancer 71 (1997) 396-401.
43. N. Brass, D. Heckel, U. Sahin, M. Pfreundschuh, G.W. Sybrecht, E. Meese, Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma, Human Mol. Genet. 6 (1997) 33-39.
44. K. Asano, W.C. Merrick, J.W.B. Hershey, The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome, J. Biol. Chem. 272 (1997) 23477-23480.
45. I.B. Rosenwald, Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells, Cancer Lett. 102 (1996) 113-123.
46. I.B. Rosenwald, D.B. Rhoads, L.D. Callanan, K.J. Isselbacher, E.V. Schmidt, Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc, Proc. Natl. Acad. Sci. USA 90 (1993) 6175-6178.
47. G.K. Haines, G. Ghadge, B. Thimmappaya, J.A. Radosevich, Expression of the protein kinase p-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms, Virchows Archiv. B Cell Path. 62 (1992) 151-158.
48. G.K. Haines, S. Becker, G. Ghadge, M. Kies, H. Pelzer, J.A. Radosevich, Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region, Arch. Otolaryngol. Head and Neck Surgery 119 (1993) 1142-1147.
49. G.K. Haines, G.D. Ghadge, S. Becker, M. Kies, H. Pelzer, B. Thimmappaya, J.A. Radosevich, Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma, Virchows Archiv. B Cell Path. 63 (1993) 289-295.
50. C. Singh, G.K. Haines, M.S. Talamonti, J.A. Radosevich, Expression of p68 in human colon cancer, Tumour Biol. 16 (1995) 281-289.
51. O. Savinova, B. Joshi, R. Jagus, Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. Int. J. Biochem. Cell Biol. 31 (1999) 175-189.
52. S. Basu, P. Panayiotidis, S.M. Hart, L.Z. He, A. Man, A.V. Hoffbrand, K. Ganeshaguru, Role of double-stranded RNA-activated protein kinase in human hematological malignancies, Cancer Res. 57 (1997) 943-947.
53. L. Beretta, M. Gabbay, R. Berger, S.M. Hanash, N. Sonenberg, Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias, Oncogene 12 (1996) 1593-1596.
54. R. Jagus, B. Joshi, G.N. Barber, PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 31 (1999) 123-138.
55. S. Taniguchi, S. Miyamoto, H. Sadano, H. Kobayashi, Rat elongation factor 1 alpha: sequence of cDNA from a highly metastatic fos-transferred cell line, Nucleic Acids Res. 19 (1991) 6949.
56. B. Ender, P. Lynch, Y.H. Kim, N.V. Inamdar, K.R. Cleary, M.L. Frazier, Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas, Mol. Carcinogenesis 7 (1993) 18-20.
57. Y. Lew, D.V. Jones, W.M. Mars, D. Evans, D. Byrd, M.L. Frazier, Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer, Pancreas 7 (1992) 144-152.
58. K. Chi, D.V. Jones, M.L. Frazier, Expression of an elongation factor 1 gamma-related sequence in adenocarcinomas of the colon, Gastroenterol. 103 (1992) 98-102.
59. S. Mathur, K.R. Cleary, N. Inamdar, Y.H. Kim, P. Steck, M.L. Frazier, Overexpression of elongation factor-1gamma protein in colorectoal carcinoma, Cancer 82 (1998) 816-821.
60. A. Duttaroy, D. Bourbeau, X.L. Wang, E. Wang, Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha, Exp. Cell Res. 238 (1998) 168-176.
61. Y. Sun, J. Lin, A.E. Katz, P.B. Fisher, Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples, Cancer Res. 57 (1997) 18-23.
62. R. Shen, Z.Z. Su, C.A. Olsson, P.B. Fisher, Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display, Proc. Natl. Acad. Sci. USA 92 (1995) 6778-6782.
63. Z. Su, N.I. Goldstein, P.B. Fisher, Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes, Proc. Natl. Acad. Sci. USA 95 (1998) 1764-1769.
64. R.V. Gopalkrishnan, Z.-Z. Su, N.I. Goldstein, P.B. Fisher, Translational infidelity and human cancer: Role of the PTI-1 oncogene. Int. J. Biochem. Cell Biol. 31 (1999) 151-162.
65. K. Pogue-Geile, J.R. Geiser, M. Shu, C. Miller, I.G. Wool, A.I. Meisler, J.M. Pipas, Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein, Mol. Cell. Biol. 11 (1991) 3842-3849.
66. J.M. Wong, K. Mafune, H. Yow, E.N. Rivers, T.S. Ravikumar, G.D. Steele Jr., L.B. Chen, Ubiquitin-ribosomal protein S27a gene overexpressed in human colorectal carcinoma is an early growth response gene, Cancer Res. 53 (1993) 1916-1920.
67. C.G.C. Larminie, H.M. Alzuherri, C.A. Cairns, A. McLees, R.J. White, Transcription by RNA polymerases I and III: a potential link between cell growth, protein synthesis and the retinoblastoma protein, J. Mol. Med. 76 (1998) 94-103.
68. H. Bielka, Ribosomes within the cell, in: H. Bielka (Ed.), The eukaryotic ribosome, Springer Verlag, Berlin, 1982, pp. 20-40.
69. V. Florian, A. Klein, A nascent micronuclear pseudogene in the ciliate Euplotes crassus, Nucleic Acids Res. 24 (1996) 3195-3200.
70. L. Espinosa, M. Martin, A. Nicolas, M. Fabre, E. Navarro, Primary sequence of the human, lysine-rich, ribosomal protein RPL38 and detection of an unusual RPL38 processed pseudogene in the promoter region of the type-1 angiotensin II receptor gene, Biochim. Biophys. Acta 1354 (1997) 58-64.
71. I.B. Rosenwald, Growth factor-independent expression of the gene encoding eukaryotic translation initiation factor 4E in transformed cell lines, Cancer Lett. 98 (1995) 77-82.
72. I.B. Rosenwald, Deregulation of protein synthesis as a mechanism of neoplastic transformation, Bioessays 18 (1996) 243-250.
73. R.M. Jones, J. Branda, K.A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, E.V. Schmidt, An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc, Mol. Cell. Biol. 16 (1996) 4754-4764.
74. N. Sonenberg, mRNA 5′ Cap-binding Protein eIF-4E and Control of Cell Growth, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational Control, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1996, pp. 245-269.
75. R.M. Frederickson, K.S. Montine, N. Sonenberg, Phosphorylation of eukaryotic translation initiation factor 4E is increased in Src-transformed cell lines, Mol. Cell. Biol. 11 (1991) 2896-2900.
76. C.W. Rinker-Schaeffer, V. Austin, S. Zimmer, R.E. Rhoads, Ras transformation of cloned rat embryo fibroblasts results in increased rates of protein synthesis and phosphorylation of eukaryotic initiation factor 4E, J. Biol. Chem. 267 (1992) 10659-10664.
77. J.R. Graff, E.R. Boghaert, A. De Benedetti, D.L. Tudor, C.C. Zimmer, S.K. Chan, S.G. Zimmer, Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts, Int. J. Cancer 60 (1995) 255-263.
78. C.W. Rinker-Schaeffer, J.R. Graff, A. De Benedetti, S.G. Zimmer, R.E. Rhoads, Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts, Int. J. Cancer 55 (1993) 841-847.
79. L.J. Mundschau, D.V. Faller, Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation, J. Biol. Chem. 267 (1992) 23092-23098.
80. A.W. van der Velden, A.A.M. Thomas, The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int. J. Biochem. Cell Biol. 31 (1999) 87-106.
81. A. Willis, Translational control of growth factor and proto-oncogene expression. Int. J. Biochem. Cell Biol. 31 (1999) 73-86.
82. A.E. Koromilas, A. Lazaris-Karatzas, N. Sonenberg, mRNAs containing extensive secondary structure in their 5′ noncoding region translate efficiently in cells overexpressing initiation factor eIF-4E, EMBO J. 11 (1992) 4153-4158.
83. L.M. Shantz, A.E. Pegg, Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. Int. J. Biochem. Cell Biol. 31 (1999) 107-122.
84. D. Rousseau, R. Kaspar, I. Rosenwald, L. Gehrke, N. Sonenberg, Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E, Proc. Natl. Acad. Sci. USA 93 (1996) 1065-1070.
85. L.M. Shantz, R.H. Hu, A.E. Pegg, Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E, Cancer Res. 56 (1996) 3265-3269.
86. A.E. Pegg, L.M. Shantz, C.S. Coleman, Ornithine decarboxylase as a target for chemoprevention, J. Cell. Biochem. 22 (Suppl.) (1995) 132-138.
87. M. Auvinen, A. Paasinen, L.C. Andersson, E. Holtta, Ornithine decarboxylase activity is critical for cell transformation, Nature 360 (1992) 355-358.
88. L.M. Shantz, A.E. Pegg, Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation, Cancer Res. 54 (1994) 2313-2316.
89. S. Pyronnet, A.C. Gingras, M. Bouisson, A. Kowalski-Chauvel, C. Seva, N. Vaysse, N. Sonenberg, L. Pradayrol, Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA, Oncogene 16 (1998) 2219-2227.
90. J.M. Manzella, W. Rychlik, R.E. Rhoads, J.W. Hershey, P.J. Blackshear, Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eucaryotic initiation factors eIF-4B and eIF-4E, J. Biol. Chem. 266 (1991) 2383-2389.
91. J.R. Graff, A. De Benedetti, J.W. Olson, P. Tamez, R.A. Casero Jr., S.G. Zimmer, Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E, Biochem. Biophys. Res. Commun. 240 (1997) 15-20.
92. L.M. Shantz, C.S. Coleman, A.E. Pegg, Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation, Cancer Res. 56 (1996) 5136-5140.
93. T. Shimogori, T. Suzuki, K. Kashiwagi, Y. Kakinuma, K. Igarashi, Enhancement of helicase activity and increase of eIF-4E phosphorylation in ornithine decarboxylase-overproducing cells, Biochem. Biophys. Res. Commun. 222 (1996) 748-752.
94. I.B. Rosenwald, A. Lazaris-Karatzas, N. Sonenberg, E.V. Schmidt, Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E, Mol. Cell. Biol. 13 (1993) 7358-7363.
95. A. De Benedetti, B. Joshi, J.R. Graff, S.G. Zimmer, CHO cells transformed by the translation factor eIF-4E display increased c-myc expression, but require Max for tumorigenicity, Mol. Cell. Diff. 2 (1994) 347-371.
96. R.J. Fagan, A. Lazaris-Karatzas, N. Sonenberg, R. Rozen, Translational control of ornithine aminotransferase. Modulation by initiation factor eIF-4E, J. Biol. Chem. 266 (1991) 16518-16523.
97. U.A. Bommer, A. Lazaris-Karatzas, A. De Benedetti, P. Nurnberg, R. Benndorf, H. Bielka, N. Sonenberg, Translational regulation of the mammalian growth-related protein P23: involvement of eIF-4E, Cell. Mol. Biol. Res. 40 (1994) 633-641.
98. Y. Gachet, S. Tournier, M. Lee, A. Lazaris-Karatzas, T. Poulton, U.-A. Bommer, submitted for publication.
99. M. Rau, T. Ohlmann, S.J. Morley, V.M. Pain, A reevaluation of the cap-binding protein, eIF4E, as a rate-limiting factor for initiation of translation in reticulocyte lysate, J. Biol. Chem. 271 (1996) 8983-8990.
100. M. Kozak, An analysis of vertebrate mRNA sequences: intimations of translational control, J. Cell Biol. 115 (1991) 887-903.
101. F.C. Nielsen, L. Ostergaard, J. Nielsen, J. Christiansen, Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway, Nature 377 (1995) 358-362.
102. F.C. Nielsen, J. Christiansen, Posttranscriptional regulation of insulin-like growth factor II mRNA, Scand. J. Clin. Lab. Invest. 220 (Suppl.) (1995) 37-46.
103. J. Bernstein, O. Sella, S.Y. Le, O. Elroy-Stein, PDGF2/ c-sis mRNA leader contains a differentiation-linked internal ribosomal entry site (D-IRES), J. Biol. Chem. 272 (1997) 9356-9362.
104. L.F. Steel, D.L. Telly, J. Leonard, B.A. Rice, B. Monks, J.A. Sawicki, Elements in the murine c-mos messenger RNA 5′-untranslated region repress translation of downstream coding sequences, Cell Growth Diff. 7 (1996) 1415-1424.
105. N.G. Theodorakis, D.W. Cleveland, Translationally coupled degradation of mRNA in eukaryotes, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational control, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1996, pp. 631-652.
106. O. Meyuhas, D. Avni, S. Shama, Translational control of ribosomal protein mRNAs, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational control, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1996, pp. 363-388.
107. W. Gan, R.E. Rhoads, Internal initiation of translation directed by the 5′-untranslated region of the mRNA for eIF4G, a factor involved in the picornavirus-induced switch from cap-dependent to internal initiation, J. Biol. Chem. 271 (1996) 623-626.
108. A. Gradi, H. Imataka, Y.V. Svitkin, E. Rom, B. Raught, S. Morino, N. Sonenberg, A novel functional human eukaryotic translation initiation factor 4G, Mol. Cell. Biol. 18 (1998) 334-342.
109. M.E. Ewen, S.J. Miller, p53 and translational control, Biochim. Biophys. Acta 1242 (1996) 181-184.
110. M.E. Ewen, C.J. Oliver, H.K. Sluss, S.J. Miller, D.S. Peeper, p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest, Genes Dev. 9 (1995) 204-217.
111. M. Harigai, T. Miyashita, M. Hanada, J.C. Reed, A cis-acting element in the BCL-2 gene controls expression through translational mechanisms, Oncogene 12 (1996) 1369-1374.
112. M. Kozak, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucleic Acids Res. 15 (1987) 8125-8148.
113. S.R. Hann, Regulation and function of non-AUG-initiated proto-oncogenes, Biochimie 76 (1994) 880-886.
114. A.P. Geballe, Translational control mediated by upstream AUG codons, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational control, Cold Spring Harbor Laboratory Press, cold Spring Harbor, 1996, pp. 173-197.
115. R.J. Jackson, A. Kaminski, Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond, RNA 1 (1995) 985-1000.
116. A.B. Sachs, P. Sarnow, M.W. Hentze, Starting at the beginning, middle and end: translation initiation in eukaryotes, Cell 89 (1997) 831-838.
117. S.Y. Le, J.V. Maizel Jr., A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs, Nucleic Acids Res. 25 (1997) 362-369.
118. H.B.J. Jefferies, G. Thomas, Ribosomal protein S6 phosphorylation and signal transduction, in: J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational control, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1996, pp. 389-409.
119. H.B. Jefferies, S. Fumagalli, P.B. Dennis, C. Reinhard, R.B. Pearson, G. Thomas, Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k, EMBO J. 16 (1997) 3693-3704.
120. V. Kruys, G. Huez, Translational control of cytokine expression by 3′UA-rich sequences, Biochimie 76 (1994) 862-866.
121. H. Prats, M. Kaghad, A.C. Prats, M. Klagsbrun, J.M. Lelias, P. Liauzun, P. Chalon, J.P. Tauber, F. Amalric, J.A. Smith et al, High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons, Proc. Natl. Acad. Sci. USA 86 (1989) 1836-1840.
122. S. Vagner, M.C. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats, A.C. Prats, Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes, Mol. Cell. Biol. 15 (1995) 35-44.
123. V. Patry, B. Bugler, A. Maret, M. Potier, H. Prats, Endogenous basic fibroblast growth factor isoforms involved in different intracellular protein complexes, Biochem. J. 326 (1997) 259-264.
124. S. Vagner, C. Touriol, B. Galy, S. Audigier, M.C. Gensac, F. Amalric, F. Bayard, H. Prats, A.C. Prats, Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells, J. Cell Biol. 135 (1996) 1391-1402.
125. J. Hata, J. Takeo, C. Segawa, S. Yamashita, A cDNA encoding fish fibroblast growth factor-2, which lacks alternative translation initiation, J. Biol. Chem. 272 (1997) 7285-7289.
126. C. Kevil, P. Carter, B. Hu, A. DeBenedetti, Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation, Oncogene 11 (1995) 2339-2348.
127. H. Teerink, H.O. Voorma, A.A. Thomas, The human insulin-like growth factor II leader 1 contains an internal ribosomal entry site, Biochim. Biophys. Acta 1264 (1995) 403-408.
128. P. Horvath, A. Suganuma, M. Inaba, Y.B. Pan, K.C. Gupta, Multiple elements in the 5′ untranslated region down-regulate c-sis messenger RNA translation, Cell Growth Diff. 6 (1995) 1103-1110.
129. C.G. Kevil, A. De Benedetti, D.K. Payne, L.L. Coe, F.S. Laroux, J.S. Alexander, Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis, Int. J. Cancer 65 (1996) 785-790.
130. R.N. Bamford, A.P. Battiata, T.A. Waldmann, IL-15: the role of translational regulation in their expression, J. Leukocyte Biol. 59 (1996) 476-480.
131. R.N. Bamford, A.P. Battiata, J.D. Burton, H. Sharma, T.A. Waldmann, Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation, Proc. Natl. Acad. Sci. USA 93 (1996) 2897-2902.
132. J.D. Marth, R.W. Overell, K.E. Meier, E.G. Krebs, R.M. Perlmutter, Translational activation of the lck proto-oncogene, Nature 332 (1988) 171-173.
133. N. Yew, M. Strobel, G.F. Van de Woude, Mos and the cell cycle: the molecular basis of the transformed phenotype, Curr. Opin. Genet. Dev. 3 (1993) 19-25.
134. M.D. Sheets, M. Wu, M. Wickens, Polyadenylation of c-mos mRNA as a control point in Xenopus meiotic maturation, Nature 374 (1995) 511-516.
135. D.S. Hoover, D.G. Wingett, J. Zhang, R. Reeves, N.S. Magnuson, Pim-1 protein expression is regulated by its 5′-untranslated region and translation initiation factor eIF-4E, Cell Growth Diff. 8 (1997) 1371-1380.
136. C. Nanbru, I. Lafon, S. Audigier, M.C. Gensac, S. Vagner, G. Huez, A.C. Prats, Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site, J. Biol. Chem. 272 (1997) 32061-32066.
137. M. Stoneley, F.E.M. Paulin, J.P.C. Le Quesne, S.A. Chappell, A.E. Willis, C-Myc 5′ untranslated region contains an internal ribosome entry segment, Oncogene 16 (1998) 423-428.
138. D. Avni, Y. Biberman, O. Meyuhas, The 5′ terminal oligopyrimidine tract confers translational control on TOP mRNAs in a cell type- and sequence context-dependent manner, Nucleic Acids Res. 25 (1997) 995-1001.
139. A.V. Borovjagin, P. Russell, M.J. Clemens, M.A. Greagg, U.A. Bommer, Features of the translational regulation of the mammalian growth-related protein P23, Biochem. Soc. Transactions 23 (1995) 316S.
140. S. Shama, D. Avni, R.M. Frederickson, N. Sonenberg, O. Meyuhas, Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells, Gene Expression 4 (1995) 241-252.
141. W.N. Gan, M. La Celle, R.E. Rhoads, Functional characterization of the internal ribosome entry site of eIF4G mRNA, J. Biol. Chem. 273 (1998) 5006-5012.
142. J.R. Hill, D.R. Morris, Cell-specific translation of S-adenosylmethionine decarboxylase mRNA. Regulation by the 5′ transcript leader, J. Biol. Chem. 267 (1992) 21886-21893.
143. J.R. Hill, D.R. Morris, Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Dependence on translation and coding capacity of the cis-acting upstream open reading frame, J. Biol. Chem. 268 (1993) 726-731.
144. H. Ruan, L.M. Shantz, A.E. Pegg, D.R. Morris, The upstream open reading frame of the mRNA encoding S-adenosylmethionine decarboxylase is a polyamine-responsive translational control element, J. Biol. Chem. 271 (1996) 29576-29582.
145. L. Hengst, S.I. Reed, Translational control of p27Kip1 accumulation during the cell cycle, Science 271 (1996) 1861-1864.
146. J. Mosner, T. Mummenbrauer, C. Bauer, G. Sczakiel, F. Grosse, W. Deppert, Negative feedback regulation of wild-type p53 biosynthesis, EMBO J. 14 (1995) 4442-4449.
147. B.M. Fontoura, C.A. Atienza, E.A. Sorokina, T. Morimoto, R.B. Carroll, Cytoplasmic p53 polypeptide is associated with ribosomes, Mol. Cell. Biol. 17 (1997) 3146-3154.
148. V. Marechal, B. Elenbaas, J. Piette, J.C. Nicolas, A.J. Levine, The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes, Mol. Cell. Biol. 14 (1994) 7414-7420.
149. J. Piette, H. Neel, V. Marechal, Mdm2: keeping p53 under control, Oncogene 15 (1997) 1001-1010.
150. M.C. Yeung, J. Liu, A.S. Lau, An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells, Proc. Natl. Acad. Sci. USA 93 (1996) 12451-12455.
151. S.D. Der, Y.-L. Yang, C. Weissmann, B.R.G. Williams, A PKR-dependent pathway mediating stress-induced apoptosis, Proc. Natl. Acad. Sci. USA 94 (1997) 3279-3283.
152. S.P. Srivastava, K.U. Kumar, R.J. Kaufman, Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase, J. Biol. Chem. 273 (1998) 2416-2423.
153. V.A. Polunovsky, I.B. Rosenwald, A.T. Tan, J. White, L. Chiang, N. Sonenberg, P.B. Bitterman, Translational control of programmed cell death: Eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc, Mol. Cell. Biol. 16 (1996) 6573-6581.
154. B.D. Keiper, W. Gan, R.E. Rhoads, Molecules in focus: protein synthesis initiation factor 4G. Int. J. Biochem. Cell Biol. 31 (1999) 37-41.
155. N. Levy-Strumpf, L.P. Deiss, H. Berissi, A. Kimchi, DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death, Mol. Cell. Biol. 17 (1997) 1615-1625.
156. M.J. Clemens, M. Bushell, S.J. Morley, Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines, Oncogene, 1998, in press.
157. B.D.L. Li, J.C. McDonald, R. Nassar, A. De Benedetti, Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression, Ann. Surg. 227 (1998) 756-763.
158. H. Aktas, R. Fluckiger, J.A. Acosta, J.M. Savage, S.S. Palakurthi, J.A. Halperin, Depletion of intracellular Ca2+ stores, phosphorylation of eIF2α, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole, Proc. Natl. Acad. Sci. USA 95 (1998) 8280-8285.
159. A. Maret, B. Galy, E. Arnaud, F. Bayard, H. Prats, Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line, Cancer Res. 55 (1995) 5075-5079.
160. R.N. Bamford, A.P. Battiata, J.D. Burton, H. Sharma, T.A. Waldmann, Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 mRNA translation, Proc. Natl. Acad. Sci. USA 93 (1996) 2897-2902.
161. R.N. Bamford, A.P. Battiata, T.A. Waldmann, IL-15: the role of translational regulation in their expression, J. Leukocyte Biol. 59 (1996) 476-480.
162. Y. Tagaya, R.N. Bamford, A.P. DeFilippis, T.A. Waldmann, IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels, Immunity 4 (1996) 329-336.
163. B. Raught, A.C. Gingras, A. James, D. Medina, N. Sonenberg, J.M. Rosen, Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells, Cancer Res. 56 (1996) 4382-4386.
164. B.T. Edmonds, J. Wyckoff, Y.G. Yeung, Y. Wang, E.R. Stanley, J. Jones, J. Segall, J. Condeelis, Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma, J. Cell Sci. 109 (1996) 2705-2714.
165. J.E. Landers, S.L. Cassel, D.L. George, Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein, Cancer Res. 57 (1997) 3562-3568.